FDA approves weight-loss drug Zepbound for obstructive sleep apnea
which was approved for weight loss for those with obesity, or who are overweight and have a weight-related health ...
Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea
The FDA suggests that prescribed users also reduce their calorie intake and increase their exercise The weight loss drug ...
FDA approves first medication for obstructive sleep apnea, which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA).On Dec. 20, ...
Hello Healthy: A New Year, New Options for Weight Loss and Better Health
Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...
HealthDay on MSN1d
Some GLP-1s Achieve More Weight Loss Than Others: Study
Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...
The Washington Post on MSN9d
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
WWNO20d
FDA approves weight loss drug Zepbound to treat obstructive sleep apnea
The weight loss drug Zepbound has become the first prescription medication approved to ... was approved by the FDA in November 2023 to treat obesity — becoming a new competitor to Novo ...
Becker's Hospital Review1d
GLP-1s cut surgery complication risk in some patients: Study
Glucagon-like peptide-1 receptor agonist drugs may reduce the risk of surgical complications in diabetic patients, according to a large new study. The study showed diabetic patients taking GLP-1 drugs ...